| ¿µ¹® | systemic lupus erythematosus | ÇÑ±Û | Àü½ÅÈ«¹Ý·çǪ½º |
|---|---|---|---|
| ¼³¸í | Àü½Å ÀÚ°¡¸é¿ªº´ÀÇ ´ëÇ¥Àû º´ÀÌ´Ù. ¿©¼º¿¡°Ô ¾ÐµµÀûÀ¸·Î ¸¹°í, 10~39¼¼±îÁö°¡ 70%¸¦ Â÷ÁöÇÑ´Ù. ¿øÀÎÀº Àß ¸ð¸£³ª ÀÚ°¡¸é¿ª Á¶Àý±â´É¿¡ Àå¾Ö°¡ ÀÖ´Â °ÍÀ¸·Î »ý°¢µÈ´Ù. À¯Àü¿äÀÎ, È£¸£¸óÀÇ ¿µÇâ, ȯ°æ¿ä¼Ò°¡ Á¾ÇÕÀûÀ¸·Î º¸Á¶ T¼¼Æ÷¿Í B¼¼Æ÷¸¦ Ȱ¼ºÈ½ÃÄѼ ¿©·¯ °¡Áö ÀÚ°¡Ç×üµé, Áï õ¿¬ DNA, ÀÌÁß°¡´Ú DNA, ¿Ü°¡´Ú DNA, RNA, ÇٴܹéÁú µî°ú °°Àº ÇÙ Ç׿ø¿¡ ´ëÇÑ Ç×ü, ºñÇÙÇ׿ø¿¡ ´ëÇÑ ¿©·¯ °¡Áö Ç×ü°¡ ½ñ¾ÆÁ® ³ª¿Â´Ù. ÀÌ Áß ÀÌÁß°¡´Ú DNA¸¦ Æ÷ÇÔÇÑ ¼øÈ¯¸é¿ªº¹ÇÕü°¡ ÄáÆÏ¿¡ Ä§ÂøÇÏ¿© ¼Õ»óÀ» ÀÏÀ¸Å°´Âµ¥ °ü¿©ÇÑ´Ù. DNA¿Í ¿©·¯ °¡Áö ¼¼Æ÷¼ººÐ¿¡ ´ëÇÑ ÀÚ°¡¸é¿ªÁúȯÀ¸·Î ÀüÄáÆÏ±â¸¦ ħ¹üÇÏ¿© ¿°ÁõÀ» ÀÏÀ¸Å²´Ù. ¿©·¯ ÀÚ°¡Ç׿ø¿¡ ´ëÇÑ ¸é¿ª¹ÝÀÀ¿¡ ÀÇÇÑ Ç×üÀÇÁ¸¼º ¸é¿ª¹ÝÀÀ°ú ¸é¿ªº¹ÇÕü ¹ÝÀÀÀ¸·Î Å丮ÄáÆÏ¿°, Ç÷°ü¿°, °üÀý¿° ¹× ºóÇ÷À» µ¿¹ÝÇÑ´Ù. |
||
| ¿µ¹® | systemic circulation | ÇÑ±Û | ü¼øÈ¯ |
|---|---|---|---|
| ¼³¸í | ¿Þ½É½Ç¿¡¼ ½Åü¸¦ µ¹¾Æ ¿À¸¥½É¹æ±îÁöÀÇ ¼øÈ¯À» ÀǹÌÇϸç, ¿Þ½É½Ç ¡æ ´ëµ¿¸Æ ¡æ µ¿¸Æ ¡æ ¸ð¼¼Ç÷°ü ¡æ Á¤¸Æ ¡æ ´ëÁ¤¸Æ ¡æ ¿À¸¥½É¹æÀÇ È¸·Î¸¦ ¼øÈ¯ÇÑ´Ù. |
||
| ¿µ¹® | sclerosis | ÇÑ±Û | °æÈ(Áõ), ±»À½(Áõ) |
|---|---|---|---|
| ¼³¸í | ¿°Áõ ¹× °£º´¿¡ ÀÇÇØ¼ ÁøÇdz» ¼¶À¯¸ð¼¼Æ÷ÀÇ Áõ½Ä°ú ¾Æ±³Áú ¼¶À¯ÀÇ Áõ½ÄÀÌ ÀÖ´Â °æ¿ì¸¦ ¸»ÇÑ´Ù. |
||
| ¿µ¹® | amyotrophic laternal sclerosis | ÇÑ±Û | ±ÙÀ§ÃàÃø»è°æÈÁß |
|---|---|---|---|
| ¼³¸í | »ç¶÷ÀÌ ±ÙÀ° Çϳª¸¦ ¿òÁ÷À϶§ »ç¿ëÇÏ´Â ½Å°æ¿¬°áÀ» »ìÆìº¸¸é ´ÙÀ½°ú °°´Ù. ¿ì¼± ´ë³ú¿¡ ÀÖ´Â ¿îµ¿À» °üÀåÇÏ´Â °÷ÀÎ ¿îµ¿°ÑÁú¿¡¼ÀÇ ¸í·ÉÀÌ ¶³¾îÁö¸é À̰ÍÀº ô¼ö¸¦ Ÿ°í °è¼ÓÇØ¼ ³»·Á¿À°Ô µÈ´Ù. ±×¸®°í ô¼ö¿¡¼ Çѹø ½Å°æ¼¼Æ÷¸¦ ¹Ù²Ù¾î¼ ¸»ÃÊ½Å°æ ±ÙÀ°¿¡ °¡¼ ±ÙÀ°À» ¿òÁ÷ÀδÙ. Áï ´ë³ú¿¡¼ ¶³¾îÁø ¸í·ÉÀÌ ½Å°æ¼¼Æ÷ Çϳª¸¦ Ÿ°í ô¼ö±îÁö °¡°í ô¼ö¿¡¼ ÇÑ ¹ø ½Å°æÀ» ¹Ù²Ù¾î ±ÙÀ°À¸·Î °£´Ù. ô¼ö¿¡¼ ½ÃÀÛÇÏ¿© ±ÙÀ°±îÁö °¡´Â ½Å°æ ¼¼Æ÷¸¦ ¾Õ»Ô¼¼Æ÷¶ó°í ÇÑ´Ù. ¿øÀÎ ¹Ì»óÀÎ ÀÌ º´Àº ¾Õ»Ô¼¼Æ÷ÀÇ ¼Ò½Ç¿¡ ÀÇÇØ¼ ±×°ÍÀÇ Áö¹è¸¦ ¹Þ´Â ±ÙÀ°ÀÇ À§ÃàÀÌ ³ªÅ¸³ª´Â °ÍÀ» ÁÖÁõ»óÀ¸·Î ÇÑ´Ù. ÀÌ º´¿¡ Ưȿ°¡ ÀÖ´Â Ä¡·á¹ýÀº ¾ÆÁ÷ ¾ø´Ù. |
||
| ¿µ¹® | multiple sclerosis | ÇÑ±Û | ´Ù¹ß°æÈÁõ |
|---|---|---|---|
| ¼³¸í | ½Å°æÃà»èÀ» µÑ·¯½Î°í ÀÖ´Â ¸»ÀÌÁý(myelin sheath)ÀÇ ÆÄ±«·Î ÀÎÇÑ º´Àû»óŸ¦ ¸»ÇÔ. ÆÄ±«µÈ ¸»ÀÌÁýÀº ÈäÅ͸¦ ³²±â°Ô µÇ¾î ½Å°æÃà»èÀ» ÅëÇÑ ½Å°æÀü´ÞÀÌ Á¦´ë·Î µÇÁö ¾Ê¾Æ ¿îµ¿, °¨°¢, ÀÚÀ²½Å°æ ¸ðµÎÀÇ ½Å°æÀü´ÞÀå¾Ö°¡ ³ªÅ¸³´Ù. ÀÌ º´ÅÍ´Â ¾îµð¼³ª ³ªÅ¸³¯ ¼ö ÀÖ¾î¼ ±× Àå¾Ö°¡ ³ªÅ¸³ª´Â ºÎÀ§¿¡ µû¶ó ¼·Î ´Ù¸¥ Áõ»óÀ» È£¼ÒÇÑ´Ù. |
||
| ALS | acute lateral sclerosis; advanced life support; afferent loop syndrome; amyotrophic lateral sclerosi... |
|---|---|
| PSS | painful shoulder syndrome; physiologic saline solution; porcine stress syndrome; primary Sjogren syn... |
| SSc | systemic scleroderma; systemic sclerosis |
| NYHA | New York Heart Association Heart Disease¿¡ ´ëÇÑ Functional Classification &nbs... |
| WDMF | wall-defective microbial forms |
| PSS | Progressive Systemic Sclerosis |
|---|---|
| SS | Systemic Sclerosis |
| SSC | Systemic Sclerosis |
| SSc; scleroderma | Systemic Sclerosis |
| DRO | Differential Reinforcement of Other Behaviour |
| systemic sclerosis | <rheumatology> A multisystem disorder of unknown aetiology. It is characterised by fibrosis (scarring) of the skin, blood vessels and internal organs. Involvement of the gastrointestinal tract, heart, kidneys and lungs is common. (09 Jan 1998) |
|---|---|
| other-directed | Pertaining to a person readily influenced by the attitudes of others. (05 Mar 2000) |
| transferases (other substituted phosphate groups) | <enzyme> A class of enzymes that transfers substituted phosphate groups. Registry number: EC 2.7.8 (12 Dec 1998) |
| accole forms | A term applied to the manner in which the ring stage of Plasmodium falciparum parasitises the marginal portion of erythrocytes. Synonym: accole forms. (05 Mar 2000) |
| applique forms | A term applied to the manner in which the ring stage of Plasmodium falciparum parasitises the marginal portion of erythrocytes. Synonym: accole forms. (05 Mar 2000) |
| atypical bacterial forms | Microorganisms that have undergone greater changes than normal in morphology, physiology, or cultural characteristics. (12 Dec 1998) |
| dosage forms | Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. They include capsules, liniments, ointments, pharmaceutical solutions, powders, tablets, etc. (12 Dec 1998) |
| forms and records control | A management function in which standards and guidelines are developed for the developing, maintaining, and handling of forms and records. (12 Dec 1998) |
| forms of DNA i, II and III | Refers to circular DNA removed from viruses and as plasmids. Form I is the DNA in its normal, supercoiled form. Form II is the DNA after one of the two strands has been nicked (cut apart), and is circular. Form III is the DNA after both strands have been broken, and is linear. (09 Oct 1997) |
| l forms | Bacterial variants, unable to form a complete cell wall, which are formed in cultures by various bacteria; granules (l bodies) appear, unite, and grow into amorphous bodies which multiply and give rise to bacterial cells morphologically indistinguishable from the parent strain. (12 Dec 1998) |
| rheumatoid arthritis, systemic-onset juvenile | Also known as systemic-onset juvenile chronic arthritis. Still's disease presents with systemic (bodywide) illness including high intermittent fever, a salmon-coloured skin rash, swollen lymph glands, enlargement of the liver and spleen, and inflammation of the lungs (pleuritis) and around the heart (pericarditis). The arthritis may not be immediately apparent but it does appear and may persist after the systemic symptoms are gone. (12 Dec 1998) |
| portal-systemic anastomoses | Naturally-occurring venous communications between tributaries of the portal venous system and tributaries of the systemic venous system. The major portal-systemic anastomoses include: 1) oesophageal branches of left gastric vein with oesophageal veins, 2) superior rectal vein with middle and inferior rectal veins, 3) paraumbilical veins with subcutaneous veins of anterior abdominal wall, 4) retroperitoneal veins with venous branches of veins of the colon and bare area of the liver, and 5) a patent ductus venosus connecting left branch of portal vein to inferior vena cava (rare). These anastomoses are important clinically, providing collateral circulation during portal obstruction or hypertension, at which time they may become varicose. See: caput medusae, oesophageal varices, haemorrhoids. Surgically-created communications between the portal vein and the inferior vena cava or their tributaries, to relieve portal hypertension. Synonym: portacaval anastomoses. (05 Mar 2000) |
| portal-systemic encephalopathy | An encephalopathy associated with cirrhosis of the liver, attributed to the passage of toxic nitrogenous substances from the portal to the systemic circulation; cerebral manifestations may include coma. Synonym: hepatic encephalopathy. (05 Mar 2000) |
| scleroderma, systemic | A chronic, progressive dermatosis characterised by boardlike hardening and immobility of the affected skin, with visceral involvement, especially of lungs, oesophagus, kidneys and heart. It may be accompanied by calcinosis, raynaud's phenomenon, and telangiectasis (crest syndrome). It includes acrosclerosis and sclerodactyly. (12 Dec 1998) |
| systemic | <anatomy> Pertaining to or affecting the body as a whole. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|